Creating a new catheter to support heart function in patients with pulmonary arterial hypertension
Official title: The Development of a Biatrial Catheter for a Cardiopulmonary Support System in Pulmonary Arterial Hypertension
Funded at Icahn School of Medicine at Mount Sinai · NIH-10972731 · Data updated 2026-11-12
This study is testing a new type of catheter that helps people with pulmonary arterial hypertension by easing pressure on the heart and improving blood flow, making it easier for them to manage their condition while they wait for a lung transplant.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 15, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $335,984 |
| NIH project number | 4R33HL163755-02 |
| Project ID | NIH-10972731 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with pulmonary arterial hypertension who may benefit from advanced cardiac support.
✕Less likely to help
Patients with mild pulmonary hypertension or those who are not candidates for catheter-based interventions may not receive benefits from this research.
What this research studies
This research focuses on developing a dual lumen catheter designed to support patients with pulmonary arterial hypertension, a serious condition that affects blood flow in the lungs. The catheter aims to relieve pressure on the right side of the heart and improve blood flow, potentially allowing patients to manage their condition more effectively. By using innovative engineering techniques, the catheter will be positioned for long-term use and will include a monitoring system to ensure optimal performance. This approach seeks to provide a bridge for patients awaiting lung transplants and improve their overall treatment outcomes.
Why it matters
Potential benefit: If successful, this research could significantly enhance the quality of life and survival rates for patients with pulmonary arterial hypertension.
How similar studies have gone: Previous research has shown promise in developing similar catheter-based support systems for cardiac conditions, indicating potential for success in this novel approach.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Benza, Raymond Louis — Icahn School of Medicine at Mount Sinai
- Study coordinator: Benza, Raymond Louis
Related research
Other NIH-funded projects on the same topics.
-
Understanding how blood flow and pressure affect lungs in PAH
This grant studies how abnormal blood flow and pressure contribute to pulmonary arterial hypertension and how patient factors shape these effects, with the aim of guiding better therapies.
-
Asporin as a double-targeted therapy and biomarker for a serious artery disease
This project tests a protein called asporin as both a treatment and a biomarker for pulmonary arterial hypertension (PAH) to help people with this life-threatening condition.
-
Platelets and fibroblasts linked to energy use in a hard-to-treat blood vessel disease
A research team at the University of Pittsburgh is studying how platelet energy metabolism and fibroblast glutamine use interact in systemic sclerosis-related pulmonary arterial hypertension to improve diagnosis and treatment.
-
A biatrial dual‑lumen catheter to help the heart and lungs in pulmonary arterial hypertension
A new double‑lumen catheter is being developed to unload the right side of the heart and protect the lungs for people with pulmonary arterial hypertension.
-
Endothelial inflammation and Src kinase in early pulmonary arterial hypertension
Researchers are studying how inflammation in the lining of blood vessels and a protein called Src kinase contribute to early lung artery remodeling in people with mild PAH.
-
Cardiopulmonary chip model to study right heart disease from high blood pressure in the lungs
A tiny heart-lung chip is being developed to understand why the right side of the heart enlarges in people with pulmonary arterial hypertension and to test targeted treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.